Ignite Creation Date:
2024-05-05 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00777361
Status:
TERMINATED
Last Update Posted:
2010-11-18
First Post:
2008-10-21
Brief Title:
Study of Uptake Break Down and Elimination of an Investigational Drug in Healthy Volunteers
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
An Open Two Period Single Dose Phase I Study of the Excretion of Radioactivity Metabolic Profiles and Pharmacokinetics Following Oral Administration of 14C-AZD3480 and the Pharmacokinetics of AZD3480 Following Intravenous Administration to Healthy Male Volunteers With Different CYP2D6 Genotype
Status:
TERMINATED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MB
Brief Summary:
This study is being performed in order to learn more about a new drug possible as treatment for people with Alzheimers Disease and other conditions with cognitive dysfunction memory and attention problems and how it is handled by the body by giving the drug to healthy volunteers with different genotypes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT No 2007-005903-16 | None | None | None |